Literature DB >> 23758498

Association of transcription factor 4 (TCF4) and protein tyrosine phosphatase, receptor type G (PTPRG) with corneal dystrophies in southern Chinese.

Kai Jie Wang1, Vishal Jhanji, Jianhuan Chen, Ricky Wai-Kei Law, Alfred Tai-Shing Leung, Mingzhi Zhang, Ningli Wang, Chi-Pui Pang, Gary Hin-Fai Yam.   

Abstract

Fuchs' endothelial dystrophy is a common type of posterior CD characterized by the development of gutta in the Descemet membrane. Recently, TCF4 was considered as a major risk gene for European FED cases. However, another recent report has shown that rs613872 was not associated with Singaporean Chinese FEDs. Recent reports indicate the genotypic heterogeneity of FEDs in different ethnic populations. It is thus essential to understand whether these genes affect the occurrence of FEDs and non-Fuchs' CD in the local population. In the present study, we screened several reported SNPs (rs2286812, rs17595731 and rs613827 in TCF4; rs7640737 and rs2292245 in PTPRG) in FED and non-Fuchs' patients with corneal dystrophies of southern Chinese.

Entities:  

Keywords:  Chinese; corneal dystrophy; protein tyrosine phosphatase; receptor type G; transcription factor 4

Mesh:

Substances:

Year:  2013        PMID: 23758498     DOI: 10.3109/13816810.2013.804098

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  11 in total

Review 1.  The Molecular Basis of Fuchs' Endothelial Corneal Dystrophy.

Authors:  Jie Zhang; Charles N J McGhee; Dipika V Patel
Journal:  Mol Diagn Ther       Date:  2019-02       Impact factor: 4.074

2.  Association of rs613872 and Trinucleotide Repeat Expansion in the TCF4 Gene of German Patients With Fuchs Endothelial Corneal Dystrophy.

Authors:  Naoki Okumura; Ryousuke Hayashi; Masakazu Nakano; Kei Tashiro; Kengo Yoshii; Ross Aleff; Malinda Butz; Edward W Highsmith; Eric D Wieben; Michael P Fautsch; Keith H Baratz; Yuya Komori; Emi Ueda; Makiko Nakahara; Julia Weller; Theofilos Tourtas; Ursula Schlötzer-Schrehardt; Friedrich Kruse; Noriko Koizumi
Journal:  Cornea       Date:  2019-07       Impact factor: 2.651

3.  Racial/Ethnic Differences in Rates of Penetrating or Endothelial Keratoplasty for Fuchs Endothelial Corneal Dystrophy Among US Medicare Beneficiaries.

Authors:  Michael A Mahr; Keith H Baratz; David O Hodge; Jay C Erie
Journal:  JAMA Ophthalmol       Date:  2016-10-01       Impact factor: 7.389

Review 4.  Association of TCF4 polymorphisms and Fuchs' endothelial dystrophy: a meta-analysis.

Authors:  Dan Li; XiaoYan Peng; HuiYu Sun
Journal:  BMC Ophthalmol       Date:  2015-06-19       Impact factor: 2.209

5.  Association of common variants in TCF4 and PTPRG with Fuchs' corneal dystrophy: a systematic review and meta-analysis.

Authors:  Lawrence C M Lau; Li Ma; Alvin L Young; Shi Song Rong; Vishal Jhanji; Marten E Brelen; Chi Pui Pang; Li Jia Chen
Journal:  PLoS One       Date:  2014-10-09       Impact factor: 3.240

6.  Repeat-Associated Non-ATG (RAN) Translation in Fuchs' Endothelial Corneal Dystrophy.

Authors:  Elisabetta Soragni; Lina Petrosyan; Tommy A Rinkoski; Eric D Wieben; Keith H Baratz; Michael P Fautsch; Joel M Gottesfeld
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-04-01       Impact factor: 4.799

Review 7.  Perspective of Future Potent Therapies for Fuchs Endothelial Corneal Dystrophy.

Authors:  Naoki Okumura; Ryousuke Hayashi; Noriko Koizumi
Journal:  Open Ophthalmol J       Date:  2018-07-23

Review 8.  Fuchs endothelial corneal dystrophy: The vicious cycle of Fuchs pathogenesis.

Authors:  Stephan Ong Tone; Viridiana Kocaba; Myriam Böhm; Adam Wylegala; Tomas L White; Ula V Jurkunas
Journal:  Prog Retin Eye Res       Date:  2020-05-08       Impact factor: 21.198

9.  Fuchs Endothelial Corneal Dystrophy: Strong Association with rs613872 Not Paralleled by Changes in Corneal Endothelial TCF4 mRNA Level.

Authors:  Monika Ołdak; Ewelina Ruszkowska; Monika Udziela; Dominika Oziębło; Ewelina Bińczyk; Aneta Ścieżyńska; Rafał Płoski; Jacek P Szaflik
Journal:  Biomed Res Int       Date:  2015-09-16       Impact factor: 3.411

10.  A new monoclonal antibody detects downregulation of protein tyrosine phosphatase receptor type γ in chronic myeloid leukemia patients.

Authors:  Marzia Vezzalini; Andrea Mafficini; Luisa Tomasello; Erika Lorenzetto; Elisabetta Moratti; Zeno Fiorini; Tessa L Holyoake; Francesca Pellicano; Mauro Krampera; Cristina Tecchio; Mohamed Yassin; Nader Al-Dewik; Mohamed A Ismail; Ali Al Sayab; Maria Monne; Claudio Sorio
Journal:  J Hematol Oncol       Date:  2017-06-21       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.